Empliciti Disease Interactions
There is 1 disease interaction with Empliciti (elotuzumab).
Elotuzumab (applies to Empliciti) liver dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
The use of elotuzumab has been associated with elevations in liver enzymes. Care should be exercised when using this agent in patients with liver impairment. It is recommended to monitor liver enzymes before the start of therapy and periodically as clinically appropriate. Interrupt treatment upon Grade 3 or higher elevation of liver enzymes. After return to baseline values, continuation of treatment may be considered.
Switch to professional interaction data
Empliciti drug interactions
There are 278 drug interactions with Empliciti (elotuzumab).
More about Empliciti (elotuzumab)
- Empliciti consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.